Linda de Wit-van der Veen

9PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Foetal development and medicineRadiology and organ imagingMedical molecular engineering of nucleic acids and proteinsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 27, 2026
PROQURE-I: a phase I study adding concurrent [177Lu]Lu-PSMA-617 to EBRT and ADT in curative intent treatment of N1 prostate cancer.

|Mar 17, 2026
Smart scanning for two: [18F]FDG dose optimization for pregnant patients using LAFOV PET/CT technology.

Ilja S Deurloo, Milou M Steemers-de Boer, Johannes H van Snick

|Mar 19, 2025
Towards harmonized holmium-166 SPECT image quality for dosimetry: a multi-center, multi-vendor study.

Lovisa E L Westlund Gotby, Martina Stella, Camille D E Van Speybroeck

|Jun 20, 2024
Lessons learned in application driven imaging agent design for image-guided surgery.

Tessa Buckle, Daphne D D Rietbergen, Linda de Wit-van der Veen

|Feb 10, 2023
Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of 177 Lu-PSMA-617 in prostate cancer patients.

Hinke Siebinga, Bastiaan M Privé, Steffie M B Peters

|Dec 14, 2022
Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough.

Hinke Siebinga, Chayenne H A M Veerman, Linda de Wit-van der Veen

Pageof 2

Frequent Collaborators

3 joint publications

Daphne M V Huizing

2 joint publications

Hinke Siebinga

2 joint publications

Wouter V Vogel

2 joint publications

Marcel P M Stokkel